Figure 3From: Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events Cumulative incidence graph comparing therapy response with therapeutic versus subtherapeutic initial drug levels shows no statistically significant difference in complete or partial response to therapy at 12 weeks among a subset of patients with proven or probable invasive fungal disease (n = 46; HR: 0.45; P = 0.07). Back to article page